The Board of Directors of Diamines & Chemicals Limited, at its meeting held on May 18, 2026, approved the reappointment of key directors and the appointment of statutory auditors for the financial year 2026-27. These decisions are subject to the approval of the members where required.

Director Reappointments

The Board approved the reappointment of Mr. Tanmay Godiawala (DIN: 07084668) as Executive Director for a term of three years with effect from February 06, 2027. Mr. Godiawala holds an MSc in Chemical Process Research and Development from the University of Leeds, UK, and possesses over 15 years of experience in R&D, scale-up, technical sales, and marketing. He is currently the Managing Director of DACL Fine Chem Limited, a wholly owned subsidiary.

Mr. Rajendra Chhabra (DIN: 00093384) was reappointed as a Non-Executive Director in the category of Professional Director for a term of three years effective November 06, 2026. A Practicing Chartered Accountant, Mr. Chhabra has been associated with the company since 2001 and plays a significant role in finance functions. The Board also approved remuneration payable to Mr. Chhabra and commission on net profits for Non-Executive Directors for FY 2026-27 to FY 2030-31, subject to member approval.

Auditor Appointments

The Board appointed the following auditors for the financial year 2026-27:

M/s S S Puranik & Associates, a firm of Cost Accountants, was reappointed as Cost Auditor. M/s CNK & Associates LLP, a Chartered Accountant firm with experience in the chemical sector, was appointed as Internal Auditor. M/s K. C. Mehta & Co. LLP, the existing Statutory Auditors, were appointed as Tax Auditors.

Diamines & Chemicals has notified the stock exchanges of an upcoming Board of Directors meeting scheduled for Monday, May 18, 2026. The intimation, dated May 08, 2026, was filed in compliance with Regulation 29 and Chapter IV of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Details

The meeting has been convened to consider and approve the Audited Financial Results of the company for the Quarter and Year ended March 31, 2026. The results will be reviewed on both a Standalone and Consolidated basis. The board may also transact other businesses as may be required with the permission of the Chairperson.

Key details of the scheduled board meeting are summarised below:

Regulatory Compliance

The board meeting intimation was submitted to both BSE Limited and the National Stock Exchange of India Limited as required under applicable listing regulations. The notice was signed by Hemaxi Pawar, Company Secretary of Diamines and Chemicals Limited, bearing Membership No. A52581.